Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board
Zoetis, an animal health company spun off from Pfizer in 2013, is taking a representative from Bill Ackman's hedge fund Pershing Square Capital Management onto its board of directors...
Related Articles
- Getting Gen-Y on Boards (of Directors) also published in forbes.com
- PepsiCo Puts Trian Business Advisor On Board also categorized in BoardMoves
- Honest Company Diversifies Its Leadership With A Second Female Board Member also categorized in BoardMoves
- DuPont's Activist Response Has Perfect Formula To Counter Trian's Nelson Peltz also written by Antoine Gara
- The CIO-Plus Of Vivint Smart Home Named To The Board Of Domo also categorized in BoardMoves
- DuPont Spinoff Fans Flames In Trian Management's Scorched Earth Fight also written by Antoine Gara
- Twitter's Jack Dorsey To Join Disney Board Of Directors also categorized in BoardMoves
- Corporate Boards: Shifting From Aging Men To New Generation Of Women? also published in forbes.com
- Cloud Foundry Board Elects EMC CTO As Chair also categorized in BoardMoves
- Target CEO Gregg Steinhafel Resigns In Data Breach Fallout also categorized in BoardMoves
Login to comment.